Oral immunization with HCV-NS3-transformed Salmonella: Induction of HCV-specific CTL in a transgenic mouse model

Gastroenterology

Volumn 121, Issue 5, 2001, Pages 1158-1166

  Wedemeyer, Heiner ^a   Gagneten, Sara ^a   Davis, Anthony ^a   Bartenschlager, Ralf ^a   Feinstone, Stephen ^a   Rehermann, Barbara ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEPATITIS C VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; IMMUNIZATION; INTESTINE LYMPHATIC TISSUE; LYMPH FOLLICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA; TRANSGENIC MOUSE; VACCINIA;

EID: 0034766336     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.29311     Document Type: Article

References (45)

1. Paris, 26-28, February 1999, consensus statement
2. Combination therapy of chronic hepatitis C: An important step but not the final goal!
3. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response
4. Analysis of a successful immune response against hepatitis C virus
5. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C
6. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C
7. Analysis of successful immune responses in persons infected with hepatitis C virus
8. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C
9. Cytotoxic T cells and viral hepatitis
10. DNA vaccines
11. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: Safety and host response
12. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients
13. Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model
14. DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins
15. Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization
16. Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice
17. Oral somatic transgene vaccination using attenuated S. typhimurium
18. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma
19. An autologous oral DNA vaccine protects against murine melanoma
20. CpG motifs as immune adjuvants
21. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA
22. Kinetic and structural analyses of hepatitis C virus polyprotein processing
23. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines
24. Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules
25. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release
26. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
27. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus
28. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C
29. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses
30. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein
31. Vaccination of chimpanzees against infection by the hepatitis C virus
32. Vaccine development for hepatitis C
33. DNA vaccine strategies for hepatitis C
34. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids
35. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria
36. Epithelial M cells: Gateways for mucosal infection and immunization
37. Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells
38. Intralymphatic immunization enhances DNA vaccination
39. CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells
40. Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-γ release in absence of detectable cytopathicity
41. Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization
42. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors
43. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif
44. Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region
45. Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome